8th German Pharm-Tox Summit

Molecular fingerprints of SGLT2 inhibitors in non-myocyte cardiovascular cell models

Cardiac pharmacology

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Session 1

Poster

Drug transport/delivery and metabolism

Drug Repurposing Strategy for Treatment of Idiopathic Pulmonary Fibrosis

Disease models, drug development

From bioinformatic profiling to the development of siRNA-loaded nanoparticle-based therapy against lung fibrosis

Oral presentation

Development of RNA-based risk assessments for cardiotoxicity in rat cardiomyoblasts and living myocardial slices

Toxicological methods and in vitro toxicology

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session. </B>


Session 2

Maximilian Fuchs

Further involvements